Enables access to rare cannabinoids via fermentation for health-and-well-being applications.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Demetrix develops microbial-fermentation technology to produce rare, high-purity cannabinoids at scale, enabling pharmaceutical, supplement and consumer-product companies to access compounds that are otherwise difficult to extract from plants. They engineer yeast systems and infrastructure to manufacture these bio-active ingredients with improved sustainability, cost-effectiveness and consistency.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Demetrix Management Team
Investors
Horizon Ventures
Tuatara Capital, L.P.
Demetrix Valuations & Financials
View real-time NPM data on Demetrix stock including daily Demetrix stock price estimates, valuation history, and historical share price information. Access Demetrix financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Demetrix pricing across six independent market signals. Looking for private company due diligence data sources on Demetrix? Get in touch to learn more.
Similar Companies
like Demetrix
Rula
Healthcare & Life Sciences
Online platform connecting people with licensed therapists for virtual mental health counseling and support services.
Vizgen
Healthcare & Life Sciences
A leader in spatially resolved, single-cell transcriptomics, the company provides innovative solutions for visualizing gene expression in situ.
Vesalius Therapeutics
Healthcare & Life Sciences
Biotech company develops RNA-based therapies for complex diseases by targeting the human transcriptome to advance precision medicine.
RayzeBio
Healthcare & Life Sciences
Develops targeted radiopharmaceutical therapies to treat solid tumors and metastatic cancers through precise intravenous delivery.
Axial Therapeutics
Healthcare & Life Sciences
Develops microbiome-based therapeutics targeting neurological disorders through gut-brain axis interventions using small molecule treatments.
Treadwell Therapeutics
Healthcare & Life Sciences
Provides software solutions and tools to help businesses track, manage and improve their ESG performance and sustainability initiatives.
Strata Oncology
Healthcare & Life Sciences
Provides precision medicine solutions through genomic profiling to match cancer patients with targeted therapies for improved treatment outcomes.
Whiterabbit.ai
Healthcare & Life Sciences
AI-powered healthcare platform uses deep learning to analyze medical images and detect early-stage cancers that human radiologists may miss.
Be Biopharma
Healthcare & Life Sciences
Develops engineered B cell medicines and protein-based therapies to treat serious diseases, focusing on innovative therapeutic solutions.
FAQ
We have answers
Demetrix stock does not trade on public stock exchanges. Demetrix stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Demetrix stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Demetrix Stock does not trade on public stock exchanges. In order to sell Demetrix shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Demetrix does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Demetrix share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Demetrix stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Demetrix stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Demetrix stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Demetrix is a private company and has not had an IPO. There is currently no Demetrix IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Demetrix IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
